Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Chronic Pain × Sufentanil × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pain 1 Neoplasms 1 Chronic Pain 1

Interventions

Fentanyl 2 6'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine 2 ziconotide 1 nabiximols 1 morphine, naltrexone combination 1 Tapentadol 1 Sufentanil 1 Naltrexone 1 Morphine 1 Ketamine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00943566 2015-09-15

A Safety and Efficacy Study of Sufentanil Transdermal System in Patients With Chronic Pain Due to Cancer

Labtec GmbH

Phase 2 Withdrawn

Neoplasms, Pain, Chronic Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡